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The classical nucleation theory finds the rate of nucleation proportional to the monomer concen-
tration raised to the power, which is the “critical nucleus size,” nc. The implicit assumption, that
amyloids nucleate in the same way, has been recently challenged by an alternative two-step mech-
anism, when the soluble monomers first form a metastable aggregate (micelle) and then undergo
conversion into the conformation rich in β-strands that are able to form a stable growing nucleus
for the protofilament. Here we put together the elements of extensive knowledge about aggregation
and nucleation kinetics, using a specific case of Aβ1–42 amyloidogenic peptide for illustration, to
find theoretical expressions for the effective rate of amyloid nucleation. We find that at low monomer
concentrations in solution and also at low interaction energy between two peptide conformations in
the micelle, the nucleation occurs via the classical route. At higher monomer concentrations, and a
range of other interaction parameters between peptides, the two-step “aggregation-conversion” mech-
anism of nucleation takes over. In this regime, the effective rate of the process can be interpreted as
a power of monomer concentration in a certain range of parameters; however, the exponent is deter-
mined by a complicated interplay of interaction parameters and is not related to the minimum size of
the growing nucleus (which we find to be ∼7-8 for Aβ1–42). © 2017 Author(s). All article content,
except where otherwise noted, is licensed under a Creative Commons Attribution (CC BY) license
(http://creativecommons.org/licenses/by/4.0/). [http://dx.doi.org/10.1063/1.4995255]
INTRODUCTION
Amyloid fibrils are insoluble linear ordered aggregates of
particularly misfolded proteins or peptides, which are closely
connected with neurodegenerative disorders.1–4 As more evi-
dence emerges that oligomers produced at the early stages
of amyloid aggregation could be the most toxic species,5–7
researchers have been keen on understanding the details of the
nucleation mechanism of fibrils, in particular, determining the
critical nucleus size nc of primary nucleation: the minimum
size that enables the extension of amyloid fibrils. Yet, due to
the transient nature of critical nuclei and the low concentration
of nuclei over the whole aggregation time course, there have
been no direct experimental methods of observing the amyloid
nucleation process.8
For now, experimental studies monitor the total fibril
mass in real time (e.g., by optical experiments10–14), obtain-
ing kinetic plots with a characteristic sigmoidal shape.15–17
An important quantity, called the lag time tlag,18,19 can then
be extracted; it is defined as the waiting time before a sharp
increase of fibril mass appears in the sigmoidal plot. This
lag time approximately holds a power-law relationship to
the initial monomer concentration C1, as originally sug-
gested by the Oosawa model,20 which considers only primary
nucleation and irreversible elongation in aggregation kinetics.
Other more advanced models that further incorporate frag-
mentation and annealing of filaments18,21,22 all retain this
characteristic relationship. Without secondary nucleation, the
power-law exponent in tlag ∼Cγ1 is approximately γ =− nc/2,
which then should enable experimental determination of nc by
plotting ln tlag against ln C1 or through a global fitting scheme
of the total fibril mass plots against time with different ini-
tial monomer concentrations as used in Ref. 23. However, the
validity of such methods of obtaining the critical nucleus size
nc depends on how closely the assumed microscopic aggrega-
tion mechanisms and kinetic equations match the actual ones
in experiments.
Before forming an amyloid, monomeric subunits in solu-
tion have to switch from their native soluble structure into
a partially unfolded intermediate state, which has a higher
free energy in solution.24–26 There are many possible con-
figurations a soluble peptide can exist in solution: the recent
simulation study9 finds the whole hierarchy, from compact
conformations rich in α-helix to a fully unfolded random
coil—definitively finding the random coil having a lower free
energy. This challenges the earlier assumption that the soluble
monomer state of Aβ1–42 is α-helical,9,27 see Fig. 1. However,
we find it is sufficient to use a two-state simplification to cap-
ture the essence of the amyloid aggregation mechanism, as has
been suggested in molecular simulations:28,29 we denote the
soluble monomer as “α-mer” (for its assumed increasing con-
tent of α helix when forming micelles), while the β-mer is the
monomeric unit of mature amyloid fibrils. We later use this
two-state simplification to schematically show two different
nucleation mechanisms as an aid to point out the weakness of
previous theoretical kinetic models on determining the critical
nucleus size.
Conventional theoretical models used to find the critical
nucleus size are usually based on the “nucleated polymer-
ization” (NP) concept (see Fig. 2). Other more complicated
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FIG. 1. Key monomeric states of Aβ1–42. The soluble monomeric state is
likely to be the random coil although theα-mer from Protein Data Bank (PDB:
1IYT) is also soluble and only slightly higher in free energy.9 The insoluble
β-mer (PDB: 2BEG) is the standard building block of amyloid fibrils.
models that add secondary nucleation, fragmentation, and
annealing processes to this NP model18,21,22 were formu-
lated based on the classical nucleation theory, where the
primary nucleation rate is proportional to Cnc1 and further
assumed a fixed nc value throughout all monomer concentra-
tion regimes. However, already in 1984, Ferrone has pointed
out that the critical nucleus size nc should change with a var-
ied monomer concentration to account for observations of the
sickle hemoglobin polymerization rate.30 The assumption of a
fixed nc value with a varied monomer concentration therefore
must be re-examined.
In recent single-molecule experiments,31–34 an alternative
two-step nucleation mechanism has been suggested: micel-
lation of α-mers (monomers in the native soluble state) fol-
lowed by a gradual conversion into β-mers within the dense
micelle (Fig. 2). Under this scenario, the nucleation rate may
or may not take the power-law scaling of the initial monomer
concentration as would follow from NP and its derivative
models. This may in turn change the previously predicted
power-law relationship of tlag. Even if the power-law scal-
ing is found to exist in practice, the physical meaning of its
exponent and its relation to the actual nucleus or micelle size
become unclear. All these questions challenge the validity of
employing these NP models in all monomer concentration
regimes.
Several theoretical studies have been proposed for the two-
step nucleation mechanism. The work by Lomakin et al. in
1997 considered the process of producing critical nuclei from
pre-formed micelles, under the assumption of a fast thermal
equilibrium between monomers and micelles before any nucle-
ation events happen.35 A more recent theoretical framework
of the two-step mechanism (the term “nucleation-conversion-
polymerization” model is used there) considered not only
nucleation of micelles but also the step-by-step conversion of
this micelle into its fibrillar form.36 However, both these stud-
ies make an assumption of a single micelle size, which was
questioned by the observed presence of multi-size micelles in
FIG. 2. Two mechanisms of amyloid nucleation.
the coarse-grained molecular simulations of the Aβ1–42 sys-
tem.29 Separately, Auer et al. derived theoretical expressions
for nucleation rates of both NP and two-step nucleation mech-
anisms, predicting the monomer concentration at a crossover
between these two mechanisms.37 However, it was not clear
what is the micelle size that optimizes the nucleation rate of
the two-step mechanism.
The main objective of our work is to first derive the nucle-
ation rates, then to estimate the critical nucleus size in the NP
mechanism and the micelle size that maximizes the nucle-
ation rate of the two-step mechanism, and finally compare
nucleation rates of NP and two-step mechanisms to estimate
the crossover monomer concentration (similar to the one in
Ref. 37). In order to fully test the capability of the two-
step model, we deliberately stay with the basic mechanism,
without considering secondary pathways (secondary nucle-
ation and fragmentation): these are not expected to contribute
significantly at the early nucleation stage.
We choose the free energy approach, originally developed
by Ferrone,38 to obtain free energy functions of intermediate
states, final products of amyloid aggregation, and compare the
free energy landscape of both nucleation mechanisms. This
not only allows the analytical calculation of nucleation rates
of variable micelle and nucleus size but also makes possible a
simplified kinetic analysis of nucleation rates. Although this
generic scheme of using free energy landscape of nucleation to
find nucleation kinetics is formally similar to the work by Auer
and Kashchiev,37,39 our work does investigate how different
micelle sizes can facilitate the conversion process, which was
not addressed before.
Aβ1–42 peptide is used as our model system since it
has been studied more than any other amyloidogenic protein;
molecular simulations are more reliable due to its affordable
small size, in turn allowing more information on thermody-
namic parameters to build free energy functions. However, our
model is generic, and only the binding energy and geometric
parameters would differ for other amyloid systems. For sim-
plicity and clarity of the main text, many of the derivations,
and the justification of parameter values in our free energy
calculation, are moved to Appendices A–D.
NUCLEATED POLYMERIZATION MODEL
Fibril structures of Aβ1–42 peptides
Within this direct nucleation route, monomeric Aβ1–42
peptides first undergo structural conversion from the α-state
into β-state and spontaneously stack along one direction to
construct a nucleus of a protofilament or fibrils with more
than one protofilaments (typically this number lies between
2 and 6).40–43 These fibrils have a twisted linear structure
along the fibril axis, making a complete pitch every 33
β-mers.44–46 Since our aim is to investigate the critical nucleus
size, which will be much less than 33 subunits, the twisted fib-
ril structure and its effect on the later free energy calculations
can be neglected.
A cut of the short length in a fibril from the results of simu-
lation and cryo-electron microscopy further indicated that each
protofilament of this fibril was aligned on the same plane.47
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FIG. 3. β-aggregate structure: the number in each β-mer refers to the order of
attachment in the nucleation process. Double sticks represent β bonds, while
single ones are side bonds of β-mers.
To portray a coarse-grained fibril structure, it is necessary
to further clarify the relative position of one protofilament
with respect to another, when they are associated together.
Although most of the detailed structural studies40,48 are not
often resolving this longitudinal aspect of monomer packing
in protofilament pairs, there are clear indications for the period
shift. As concluded in a computation study of periods of heli-
cal twisting of single and paired protofilaments,49 the second
protofilament is shifted by half a period. That is, the lateral
monomer binds in the middle between two subunits of the
existing filament, making equal-strength diagonal bonds with
both. Based on these facts, we construct the coarse-grained
structures of single, paired, and multiple protofilaments, as
illustrated in Fig. 3. Two types of bonds are then involved in
these fibril structures: the end-to-end bond between two
β-mers, with a binding energy ∆β , and the lateral (side)
bond for two neighboring monomers from two different
protofilaments, with a binding energy ∆s each.
Free energy functions of fibrils
To construct the free energy of a protofilament, we use the
approach originally used by Ferrone.30,38 This method follows
the free energy change of a given species along the reaction
path, relative to the reference state of pureα-monomers in solu-
tion. The formation of an N-size aggregate is a process where
N monomers undergo an internal transition into β-state, with
a conversion free energy penalty ∆c, and then flock together
to form bonds within the N-size aggregate. In this process,
the translational and rotational free energies of free monomers
in solution are lost, but this loss is offset by the translational
and rotational free energies of an N-size aggregate as a whole.
For simplification, the difference in rotational and standard
translational free energies between a monomer and the N-size
aggregate is neglected, as this difference is of the magnitude
ln N with a coefficient of 3 kBT only,38 while all other inter-
action free energies have a higher dependence on N and with
coefficients of tens of kBT (see Appendix A).
From the bond scheme in Fig. 3, the free energy func-
tion of an N-size aggregate of a single protofilament takes the
following form:
Fβ,1(N) = (1 − N) (µ0 + kBT ln C1) + (N − 1)∆β + N∆c. (1)
Here µ0 is the sum of translational and rotational free ener-
gies of a single α-mer at a standard concentration of 1 mM.
Strictly, µ0 includes many internal rotational degrees of free-
dom of a peptide subunit in solution, most of which become
frozen when the monomer adopts the closely packed β-sheet
configuration in the filament. For this reason, it is hard to
accept any theoretical estimate for µ0 based on the ideal-gas
statistics. Therefore, we shall use an estimate for µ0 based on
the experimental measurement of elongation free energy (see
Appendix A for details on all material parameters). The esti-
mate gives µ0 = −34.5 kBT , for room temperature T = 25 ◦C,
and we will use this definition in the remainder of this work.
The initial monomer concentration in solution is C1, in the
units of mM (with the reference monomer concentration of
1 mM that we shall use throughout this work). Values of
the free energy of the longitudinal β-bond and the conver-
sion free energy in solution are also discussed in Appendix A:
∆β = −44 kBT50 and ∆c = 20 kBT .28
Similarly, the free energy for a paired protofilament will
be
Fβ,2(N) = (1 − N) (µ0 + kBT ln C1)
+ Ns(N)∆s + Nβ(N)∆β + N∆c. (2)
Here N s(N) is the number of lateral (side) bonds in an N-size
protofilament pair: it is zero for N ≤ 2, and we assume a
symmetric N s = (N  1) for larger N values. The free energy
of a side bond ∆s = −22 kBT .51 Finally, Nβ(N) is the number
of longitudinal β-bonds of energy∆β in a paired protofilament
of N-length, which is zero at N = 1, equal to 1 at N = 2, and
then (N  2) for other N values (cf. Fig. 3).
It is noticeable that lateral addition of one β-mer to a pre-
formed protofilament would give an interaction energy of 2∆s:
almost exactly the same magnitude as ∆β . It immediately sug-
gests that lateral addition is equally likely as addition along
the fibril axis and shall be experimentally observed in fibril
formation. This indication is indirectly supported by the fact
that no mature fibrils have frayed ends in amyloid aggrega-
tion, which means that a protofilament pair is likely to form
at the phase of amyloid nucleation, and is further reinforced
by observations of lateral addition at the early stage of fibril
formation of human amylin.52
Obviously, multi-protofilaments will have more protofila-
ments joined through lateral addition. To initiate the growth of
an extra protofilament by the side addition of one β-mer to the
pre-existing β-aggregate contributes the binding energy of 2∆s
only, which is weaker than (∆β +∆s) of an alternative addition
of one β-mer on the fibril end to keep the original protofil-
ament number. Therefore, multi-protofilament cases will not
have a more favorable bond free energy, and thus the aggre-
gation free energy would not favor the multi-protofilament
over the paired case at the nucleation stage. The difference
between the protofilament pair and the multi-protofilament
lies in that a larger critical nucleus and a higher nucleation
free energy barrier are required for multi-protofilament nucle-
ation. The presence of multi-protofilament cases in mature
Aβ1–42 fibrils is due to other free energy contributions that
originate from the twisted structure of fibrils and will become
significant as fibrils grow longer.46 But this effect does not
contribute at the nucleation stage where the aggregate size
is small, and its analysis is outside the scope of this work.
Consequently, multi-protofilament cases will not be discussed
further.
The comparison of free energies of a single and a
paired protofilament is given in Fig. 4. Due to the increase
of the number of bond sites per monomer addition in the
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FIG. 4. Aggregation free energy of a single protofilament and a protofilament
pair, Fβ,1(N , C1) and Fβ,2(N , C1), as functions of the number of aggregated
peptides N with three initial monomer concentrations in solution: C1 = 10 mM
(solid lines), 1 mM (dashed), and 1 µM (dotted). The units of the y-axis are
kBT at room temperature.
protofilament pair when N exceeds 3 (one at the end and the
other on the side of the protofilament), the protofilament pair
has a lower free energy than a single protofilament with the
same number of units. A thermally stable aggregate is the one
that should have a larger population than monomers, when
thermal equilibrium is reached, i.e., a negative free energy with
respect to the reference state chosen to be α-monomers in solu-
tion. Single protofilaments cannot be thermally stable and must
transform into protofilament pairs through lateral addition at
the early stage of nucleation. We therefore conclude that the
critical nucleus size is always nc = 3 in the paired protofila-
ment. The free energy barrier of aggregation in the NP model
is then equal to Fβ,2(3, C1).
The nc value we predict here is not the same as, albeit
close to nc = 2, that obtained by recent experimental studies of
Aβ1–42.8,53 This inconsistency may be due to the denaturant
used in experiments (i.e., sodium azide) to initiate amyloid
aggregation, which can significantly change the interactions
between monomers, and our interaction parameters do not
cover this effect. Kashchiev and Auer also analyzed the nucle-
ation free energy of β strands in a 2D nucleus model,39 yet
they concluded a variable critical nucleus size, which we do
not observe in the examined concentration regime. In their
work, the nc value starts from a rather large size (over 40
β-strands) at a low concentration and then shrinks as the func-
tion of 1/(ln C1)2. In this sense, our result as well as the
experimental work by Knowles53 is likely to fall within the
high concentration/saturation regime, where further increase
in the concentration can cause a little effect on the criti-
cal nucleus size than at a rather low concentration regime
Kashchiev and Auer were interested in.39 However, later in
this paper, we will demonstrate that the two-step mecha-
nism of nucleation becomes prevalent at higher monomer
concentrations.
Our conclusion is that critical nuclei are exclusively in
the form of paired protofilaments. We have argued above that
multi-filaments would definitely have a higher free energy
and be less favourable at the nucleation stage. Experimentally,
only pair- and multi-protofilament aggregates were observed
by different groups at neutral pH;54–56 even at low pH = 2
the fibrils composed of a protofilament pair were observed in
Ref. 57. Therefore, we are safe in excluding the single protofil-
ament nucleation, which agrees with our analysis above,
Fig. 4.
Nucleation rate of the NP mechanism
Since the rate-limiting (slow) process is actually the nucle-
ation itself, while the subsequent elongation is fast, we could
take the rate of producing (nc + 1)-mers, i.e., tetramers here, as
the measure of the nucleation rate in the NP model. We assume
the pre-thermal equilibrium for the population of the critical
nucleus size, C1 exp [−Fβ,2(nc, C1)/kBT ], with nc = 3 here and
then use the theoretical expression for the elongation rate for
the pre-existing fibril obtained in Ref. 58.
Two consecutive processes are involved in elongation:
the diffusive arrival of a monomer at the fibril end and
the attempt to cross an additional free energy barrier to
achieve internal conversion, leading to a frequency factor
exp (−∆Fel/kBT )/(τD + τI ),58 see Appendix B for derivation.
Here ∆Fel is the barrier to overcome in elongation and is
roughly 3.42 kBT for Aβ1–42 peptide.59,60 τI is the time scale
for internal α to β rearrangement of amyloidogenic species
(the value of τI is estimated as 105 s in Appendix A), while
τD is the arrival time to the fibril end. The rate of producing
tetramers is the product of this frequency factor and the con-
centration of trimers given above. We choose to express this
rate as a product,
k1C1 =
C1
τD + τI
e−[Fβ,2(3,C1)+∆Fel]/kBT , (3)
in order to isolate the specific rate constant, k1, of dimen-
sionality of inverse time. This rate constant is interpreted as
the nucleation rate constant for the NP mechanism. The arrival
time τD is the Smoluchowski diffusion rate in solution (assum-
ing no crowding effects). Taking into account the non-spherical
shape of critical nuclei, one can modify the Smoluchowski
theory for bimolecular reaction rate constants,61 as well as the
Stokes-Einstein equation for diffusion coefficients, producing
the estimate 1/τD = 4kBTC1fgeo/3ηr1, where η is the solvent
viscosity and r1 is the hydrodynamic radius of one α-mer
in solution. Note that 4kBTC1/3ηr1 is the classical Smolu-
chowski result, modified here by the geometrical factor fgeo
that accounts for the shape of the β-aggregate (this geometry
factor makes only a small correction and will not influence the
conclusions we make in this paper). With this expression for
the arrival time, the rate constant of the NP mechanism, k1 in
(3), is expressed as
k1 =
fgeoC1
fgeoτI C1 + 3ηr1/4kBT e
−[Fβ,2(3,C1)+∆Fel]/kBT
. (4)
Equation (4) shows that k1 is proportional to C31 when the
monomer concentration C1 is low and the term fgeoC1τI can
be neglected in the denominator [remember that Fβ,2(3, C1) is
proportional to −2 ln C1]. In contrast, when the term fgeoC1τI
dominates in the denominator at high monomer concentra-
tions, the rate constant only has the square of the C1 con-
centration left, k1 ∝ C21 . Note that the rate of nucleation is
frequently written in a different form, as in classical nucleation
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theory,18,20 knCnc1 , isolating all of the monomer-concentration
dependence in the scaling factor with the exponent nc equal to
the critical nucleus size. In that case, the parameter nc would
be equal to 4 at low C1, changing to nc = 3 at high C1.
TWO-STEP NUCLEATION MECHANISM
Micellation of soluble peptides
Several experiments have reported that amyloidogenic
proteins or peptides in their native state can coalesce into a
single micelle (some papers may use the term oligomer in this
context) utilizing solvent-exposed hydrophobic patches on the
surface of monomers.62–65 For example, taking lysozymes (a
type of amyloidogenic proteins), micelles have a lower content
of α-helix and a higher content of β-sheet yet with the major-
ity being disordered loops compared with native monomeric
units.65 Therefore, aggregated micelles are often classified as
amorphous. It is suggested that these amorphous micelles serve
as intermediates or initiation states for amyloid nucleation.66
This generic hypothesis of the role of micelles is indirectly
hinted by the increase in the β-sheet structural content while
losing their original α-helix content65 and is further supported
by molecular simulation of coarse-grained peptides.29,67 These
facts imply an alternative aggregation pathway for amyloid
fibrils: the two-step nucleation mechanism as described in
Fig. 2.
In our work, micelles are defined as composed of a few
α-mers aggregated from solutions. Though micelles could
have a variety of structures,68 we will assume them to be
amorphous globular aggregates of densely packed monomers
for simplicity. The driving force for micellation of Aβ1–42
peptides originates mainly from the hydrophobic interaction
between α-mers.29,69 We define one α-bond as the bond
formed between a pair of α-mers inside a micelle. The total
number of such α bonds, Nα(N), for a spherical N-size micelle
can be assumed to have the bulk and surface terms. Since the
expression Nα(N) has to reduce to Nα(2) = 1, it is easy to
obtain Nα(N) = AN+(1−2A)2−2/3N2/3, with just one unknown
parameter A.
With only the hydrophobic attraction accounted for, an
infinite micelle size could be expected in equilibrium. How-
ever, aggregation is constrained by other unfavorable free
energy factors, e.g., the electrostatic repulsion due to accumu-
lation of negative charges on the surface70 and the entropic
loss from the compact packing of several α-mers into a
micelle.71 Therefore, a large micelle size is never observed in
experiment.
A crude but convenient way to estimate the electrostatic
repulsion is to assume that electrostatic charges distribute
evenly on the spherical surface of the packed micelle. Then
the repulsion energy is (Nqe)2/8pi0rN ,72 where qe is the
effective charge on a single α-mer,  and 0 are the relative
dielectric constant and the permittivity in vacuum, respec-
tively, rN is the radius of the N-size micelle, proportional to
N1/3 if we assume that it is roughly spherical. Accordingly, the
electrostatic potential energy has the overall scaling of N5/3.
The screening effect from counter ions in solution may
challenge the validity of using the expression (Nqe)2/8pi0rN
for the potential energy of electrostatic repulsion. However,
this Debye screening effect requires mobile charges in ther-
mal motion. Without a doubt, it would exist between any two
charged micelles or monomers in solution. Yet the potential
energy quoted above refers to the energy to confine charges in
a small volume when starting from a well-separated distance
(i.e., the interaction of immobile surface charges across the
packed micelle itself). In this case, no counter charges exist
inside micelles, and even if there were some, they would have
very little mobility due to the compactness of the internal struc-
ture. Therefore, the Debye screening effect cannot play a role.
This enables the use of electrostatic potential in an effective
dielectric medium in our case.
In addition, there is an entropic cost of forcing polar amino
acid groups to the micelle surface, an effect well-studied in
the formation of micelles of polar surfactants.71 The sim-
plest expression of the free energy expressing this reduction
in conformational freedom turns out to scale as N5/3, in an
analogy to the electrostatic repulsive energy of a sphere with
an evenly distributed surface charge.73 Although the actual
entropic repulsion term can be of more complex forms, this
N5/3 scaling can be the leading term and helps us to correctly
predict the experimentally determined concentration threshold
where monomers start aggregating into micelles.71 Therefore,
we account for these two repulsive free energy contributions
(electrostatic and entropic) as a single term hN5/3, with its
parameter h to be determined.
Assembling together the free energy of α bonds and
the repulsive free energy terms, the micellation free energy,
Fmic(N, C1), can be written as
Fmic(N , C1) = (1 − N) (µ0 + kBT ln C1) + hN5/3
+∆α
[
AN + (1 − 2A)2−2/3N2/3
]
. (5)
Note a close resemblance of this expression with Eqs. (1) and
(2) for protofilaments. Here the important parameter is ∆α, the
free energy of an attractive α-bond, which is approximately
−17 kBT estimated from the work of Hills and Brooks74 (see
Appendix A). Fmic(N, C1) is analogous to the free energy
of micelle formation in surfactant solutions or flocculation
in colloids. At a certain threshold monomer concentration,
monomers and micelles of a specific size are equally favored
at thermal equilibrium; this is the “critical micelle concentra-
tion” (cmc), and the corresponding micelle size is the “critical
micelle size” (cms). In fact, the presence of the critical micelles
in the Aβ peptide system with different solvents and pH values
has been already reported.35,75–77
The micellation free energy, Fmic(N, C1), and the slope
of Fmic(N, C1) are both zero at N = cms, as in any coexisting
equilibrium. These two independent conditions let us evaluate
the parameters A and h from experimentally determined val-
ues of cmc = 17.6 µM and cms = 25, which were measured
in the solvent system that more closely reproduces the physi-
ological conditions.64 In this way, we obtain the parameters to
be used in the rest of this work: A = 4.86 (dimensionless) and
h = 1.6 kBT. Both values make good physical sense although
we shall not spend any more time on this discussion.
We can now plot Fmic(N, C1), at cmc and several other
values of monomer concentration, in Fig. 5. At low monomer
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FIG. 5. Micellation free energy Fmic(N, C1) (in units of kBT at room temper-
ature) vs. the micelle size N. From top to bottom: C1 lower than the threshold
monomer concentration to have metastable micelles (0.5 µM), C1 = cmc
(17.6 µM), and C1 well above cmc (50 µM). Nh and N l are the local maximum
and minimum of Fmic(N, C1), respectively.
concentrations (below approximately 1 µM for our chosen
set of parameters), Fmic(N, C1) is a monotonically increas-
ing function of N, and no metastable micelles can exist. This
threshold concentration can be easily derived from (5). It is
therefore impossible to have the two-step nucleation mech-
anism for amyloid aggregation below 1 µM in the Aβ1–42
system. When the monomer concentration exceeds 1 µM,
Fmic(N, C1) has a metastable state and a free energy barrier to
cross to reach a micelle. We define the micelle size that gives
the barrier position as Nh and the size that sits at the lowest
point of the free energy trap as N l, both labeled in Fig. 5. Only
micelles with the size between Nh and N l are metastable and
can follow the two-step nucleation mechanism. The explicit
form of Nh is cumbersome, but in essence, it varies between
∼8.5 at the lowest C1 end (C1 = 1.5 µM) and ∼2.5 at the high-
est C1 (7.4 mM), across the concentration range which we will
be examining in this paper.
Conversion of micelles
Based on the two structural facts about fibrils, we can
assume that α-β conversion happens on the surface of the
remaining α-mers in the packed micelles as schematically
illustrated in Fig. 2. First, due to the twisted structure of β-
aggregates, it would cost more free energy to twist inside a
dense amorphous micelle than being unconstrained on the
surface of this micelle.46 Besides, α-mers interact with the
pre-formed β-aggregate mainly at the end of the emerging fib-
ril. This is because the region of exposed hydrophobic groups
designed to attach to the β-aggregate is on the end of a β-stack.
Accordingly, α-mers tend to gather near the end area of the
fibril to gain more interaction energy.
We choose x ∈ (0, N), the number of converted α-mers,
as the reaction coordinate in the micelle of size N. The free
energy along the conversion path, Fc(N, x, C1), is composed
of four contributions: the free energy of a remaining (N  x)-
size micelle, Eq. (5); the free energy of the emerging x-size
β-aggregate, Eq. (2); the bonding free energy of an interface
between the micelle and the aggregate, which will be detailed
later; and an additional free energy loss of −(µ◦+kBT ln C1) in
translational and rotational motions, which is to compensate
for one degree of center-of-mass freedom that is present in
separate expressions for the α-micelle and the β-aggregate,
but is removed when they are bound and move as one entity.
Organizing these separate terms, the conversion free energy
Fc(N, x, C1) takes the form
Fc(N , x, C1) = (1 − N) (µ◦ + kBT ln C1) + h(N − x)5/3
+ ∆αNα + ∆αβNαβ(N , x)
+ x∆c + ∆sNs(x) + ∆βNβ(x), (6)
where Nα = A(N −x)+ (1−2A)2−2/3(N −x)2/3 for the remain-
ing micelle and ∆αβ is the free energy per αβ bond, which is
defined as the bond formed between an α-mer and a β-mer.
This is a parameter we know the least about; the range of rea-
sonable ∆αβ values is given in Appendix A. We now proceed
to find the expression for Nαβ(N , x), the number of total αβ
bonds in this intermediate aggregate.
Under the assumption that αβ bonds originate from the
replacement of pre-existing α bonds and that the emerging
β-aggregate is located on the surface of the micelle, we can
compare two expressions for Nα—one including the β-mers at
the contact interface as yet non-converted α-mers and the other
one with an actual remaining (N  x) α-mers. The resulting
expression is a non-linear function of N due to the surface
term present in the definition of Nα. When x is smaller than 3
(giving only a single protofilament geometry), the number of
αβ bonds is Nαβ(N , x) = Nα(N − x + 1) − Nα(N − x). On the
other hand, when x ≥ 3 (paired protofilament starting to form),
Nαβ = Nα(N − x + 2) − Nα(N − x) − 1, where the additional
1 is due to the replacement of one original α bond with the
β bond that bridges two protofilaments on the micelle surface
instead of contributing to Nαβ(N − x).
In Fig. 6, we examine the conversion free energy of a
hexamer (N = 6) as an illustration of the two key features of
free energy evolution during conversion: the “peak” and the
“trap” in Fc(N, x). The peak of the conversion free energy
is always at x = 2 no matter how strong the coupling ∆αβ
is. This is a generic characteristic for the micelle size larger
than 4 due to the presence of the second protofilament at
x = 3, almost doubling the number of αβ bonds and causing
an enormous stabilizing effect to drag down the value of Fc.
FIG. 6. Free energy of conversion Fc of a hexamer (N = 6) at a monomer
concentration of 1 mM, as a function of the conversion fraction x, for three
∆αβ values: 18 (dotted line), 20 (dashed), and 22 (solid) (in units of kBT ).
∆Fc is the conversion barrier. The peak of Fc occurs at x = 2, while the “trap,”
if present, is at x = 1.
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A local free energy minimum, which we call a “trap,” could
exist, just before this barrier, at x = 1 (a minimum appears
at ∆αβ =−22 kBT in Fig. 6). The difference Nαβ(N , 2)
−Nαβ(N , 1) is negative, while the difference in Nαβ is
positive between x = 1 and x = 0; this assures that the trap
can only be at x = 1. It should be noted that even though the
local minimum appears only at ∆αβ = −22 kBT in the hex-
amer case of Fig. 6, it can be present at other ∆αβ values with
a larger micelle size, when the value of Nαβ(N , 1)−Nαβ(N , 0)
and the negative value of the difference Fc(N, 1, C1)  Fc(N,
0, C1) increase.
The conversion barrier for an N-size micelle, ∆Fc, is
defined as the free energy difference between the peak and
the minimum (the “trap” or x = 0) along the reaction coordi-
nate of conversion. In other words, the barrier∆Fc is evaluated
either as the difference Fc(N, 2)  Fc(N, 0), or instead as Fc(N,
2)  Fc(N, 1) when a trap is present, as eventually always hap-
pens at a sufficiently large N. As a result, ∆Fc is not a simple
single-valued function.
Nucleation rate of the two-step
nucleation mechanism
Each individual nucleation path in the two-step mecha-
nism is characterized by the final size N of the micelle that
forms along the pathway. The nucleation free energy land-
scape is plotted with combined Fmic and Fc. For the micelle
size between Nh and N l (see Fig. 5), the nucleation free energy
landscape has two barriers: one for the micelle formation and
the other for the α-β conversion with a metastable (intermedi-
ate) state in between. This pathway is illustrated in Fig. 7 for
the case of a hexamer micelle (N = 6) and C1 = 1 mM. The plot
starts with the expression for the micelle free energy Fmic(N),
which passes over the micelle nucleation barrier Nh ≈ 3 and
then starts decreasing towards the micelle minimum (which for
this concentration will be N l = 35). However, at the micelle
size N = 6, the α-β conversion starts and the remaining part of
the plot gives the free energy Fc(6, x). This part is not a contin-
uous but a piece-wise function of x, same as in Fig. 6, because
FIG. 7. Nucleation free energy landscape of a hexamer (N = 6) for C1 = 1 mM
and ∆αβ = −18 kBT . Note the “composite” nature of the x-axis: The left
half of the plot is in the reaction coordinate for micellation, N, and the free
energy function here is Fmic(N). The right half is plotted along the conversion
coordinate, x, and producing Fc(x) values. Two barriers (∆Fmic and ∆Fc) and
three key states are labeled in the plot. Fm is the free energy of the intermediates
(in this example: the N = 6 micelle before conversion).
the expressions for the bond counts N s, Nβ , and Nαβ are all
piecewise. This, however, does not affect the conclusions on
the barrier height or kinetic parameters calculated below. This
overall free energy profile allows the use of a three-state kinetic
model.
Several ways can be used to approach this three-state
kinetics problem, a most direct being the application of the
general Kramers-style analysis of steady-state flux.78,79 How-
ever, even a simpler problem, with just one variable (degree
of freedom) and a potential with two maxima surrounding the
intermediate state, cannot be solved analytically except in lim-
iting cases when one barrier is much higher than the other. In
this work, this is further complicated by the fact that we have
two separate variables, N for the micelle size and x for the
degree of conversion, and in most cases, the free energy barri-
ers in Fig. 7 are not high, when viewed from the intermediate
state. Therefore, no formal analytical solution is anticipated in
this diffusion-type scheme.
Instead, we choose a different method of evaluating the
overall nucleation rate. We separate the nucleation process into
three distinct elements: the transition rate of association from
the monomer into the intermediate state (written as k+C1), the
reverse transition rate of dissociation from the intermediates
back to monomers (as k

Cint), and the transition rate of con-
version from the intermediate state into the final β-aggregate
state (kcCint), where Cint is the concentration of micelles (the
intermediate species). Then we derive the effective nucleation
rate from monomers to the final aggregate, defined as k2C1,
and its rate constant k2. As with the NP rate constant k1, we
choose to define the specific rate constant of the two-step
mechanism k2 in such a way in order to preserve its fixed
dimensionality.
Strictly, there has to be a reverse process from β-
aggregate back to the intermediate micelle state and also a
process of “explosive” instant dissociation of β-aggregate into
monomers. These two processes are necessary if one is to find
an equilibrium steady-state solution to this problem. How-
ever, our interest is to study the amyloid nucleation from
solution, which is a very non-equilibrium process: the first
stage of a fibril growth process leading to much lower free
energy states where one would need to investigate the pos-
sible equilibration.22 Besides, the subsequent elongation of
the aggregate larger than the critical nucleus size is usually
rather rapid, and therefore the reverse conversion from the
final aggregate state back to the metastable state is slow and
can be ignored. Consequently, we ignore the two very low-
probability processes and regard the final β-aggregate state as
irreversible.
We use a strategy similar to the probabilistic single-
molecular approach by King and Altman tackling the
Michaelis-Menten enzymatic reaction.80 Evaluation of the
average time to reach the final state of nucleation, made up of
an infinite number of paths with varied times of repeated micel-
lation and dissociation processes, gives the effective nucleation
rate constant in one two-step mechanism path, k2, which is
expressed as follows (see Appendix C for derivation):
k2 =
k+kc
2k+ + k− + kc
. (7)
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Although this effective rate constant k2 is slightly differ-
ent from the traditionally used expression (see Ref. 81,
for instance), Eq. (7) recovers the average rate constant of
the steady-state approximation, where the assumption that
kc + k−  k+ is used, giving the more familiar expression k2
= k+kc/(kc + k). Two limiting cases further validate Eq. (7).
When kc  k−, k+, then the rate limiting process is the
micelle formation, and k2 = k+. This result is reasonable since
the metastable species quickly converts into the aggregate.
The other limiting case is when k−  k+, kc. In this case
k2 = k+(kc/k−)  k+, which reflects the alternating between
the monomeric and intermediate states: completion of the reac-
tion becomes a rare event. Both are also limiting cases of the
steady-state kinetics.
We now proceed to find explicit expressions for the rate
constants k+, k, and kc. A convenient way to estimate the
micellation rate of N monomers is to separate the formation of
an N-size micelle into the formation of one (N  1)-size pre-
micelle followed by one α-mer attachment. In this scheme,
we use the Smoluchowski rate of forming a spherical micelle
of size N, 4piDm(r1 + rN−1)CN−1C1, where Dm is the mutual
diffusion coefficient, CN1 is the concentration of (N  1)-size
micelles, and r1 and rN1 are the radii of one monomer and
an (N  1)-size micelle.82 To form an (N  1)-size micelle,
there is a free energy barrier ∆Fmic to cross since (N  1) is
always larger than Nh in the three-state kinetic model. To find
the concentration CN1, we separate it into two parts: a pre-
thermal equilibrium concentration of Nh-size micelles is first
assumed to be reached and then the simultaneous adsorption of
(N  Nh  1) monomers to this pre-micelle takes place, which
is assumed to act as a deep adsorbing sink (see Appendix D
for derivation). Assembling the terms, k+ takes the form
k+ = ω+e−∆Fmic/kBT , (8)
where ω+ =
2kBT
3η C
N−Nh
1
(
2 + 3
√
N − 1 + 1
3√N − 1
)
·

4pir31
3 (1 +
3
√
Nh)3

N−Nh−1
.
From Eq. (5), it is clear that e−∆Fmic/kBT is proportional to CNh−11 .
Consequently, the product k+C1 implicitly has the factor CN1
in it and therefore corresponds to the kinetic expression for the
N-particle collision, which validates our formulation for the
constant k+.
In a system where the monomer concentration is main-
tained constant (either by re-supplying the depleted molecules
from a reservoir or simply ignoring the small change at the
nucleation stage), the micelle dissociation rate constant k

can
be derived from an argument based on the thermal equilibrium
condition that requires the dissociation rate equal to the micel-
lation rate, namely, the equation k− = k+ exp(Fm/kBT ). The
expression for k

is then
k− = ω+e−[∆Fmic−Fm]/kBT . (9)
Here Fm is the free energy of the metastable state: the micelle
of size N, see Fig. 7. The expression for Fm has the term of
(1−N)kBT ln C1 arising from Eq. (5) or (6), and therefore the
product of CN−Nh1 inω+ and exp[−(∆Fmic−Fm)/kBT ] does not
have the explicit power-law dependence on C1. The rate con-
stant k

depends on C1 only implicitly, and weakly, through
Nh that appears in ∆Fmic. At a fixed monomer concentration,
an increase in N decreases the value of k

by having a larger
negative α and αβ bond free energies in ∆Fmic − Fm, which
results in a smaller probability to break all the bonds into
monomers.
The rate constant of the conversion reaction, kc, is found
directly from the Kramers escape theory and is the product
of the activation factor over the barrier ∆Fc and the attempt
frequency from thermal fluctuations of positions of the Aβ1−42
segments, 1/τI , which has first appeared in the derivation of
k1, Eq. (3),
kc =
1
τI
e−∆Fc/kBT . (10)
With the three rate constants determined, we can write
down the overall rate of amyloid nucleation k2 for a given size
N. The full expression is cumbersome but let us examine k2 in
two limiting cases. One is k2 ≈ k+ when kc  k−, k+ (micelle
formation from solution is the rate-limiting process); the other
is k2 ≈ k+(kc/k−) when k−  k+ and kc (conversion of a
micelle is the rate-limiting process). These two extreme cases
give the expressions of ω+e−∆Fmic/kBT and e−(Fm+∆Fc)/kBT/τI ,
respectively. When conversion is the major barrier, k2 depends
on the highest free energy, i.e., Fm +∆Fc, cf. Fig. 7, and is the
product of a quasiequilibrium population for the metastable
state and the probability to cross the conversion barrier. On the
other hand, when the micellation process is slow, k2 depends
on the ∆Fmic barrier only. In general, Eq. (7) is a mixture of
these three kinetic processes.
The fastest growing nuclei
Since the monomer concentration in experiments mostly
is within the range from µM to a few mM, and using the stan-
dard concentration of 1 mM, we let ln C1 vary from 6.5 (i.e.,
C1 ≈ 1.5 µM, approximately the threshold monomer concen-
tration to initiate the two-step mechanism, discussed in the
section titled Micellation of soluble peptides, Fig. 5) up to
ln C1 = 2 (corresponding to C1 ≈ 7.4 mM). Values of C1 out-
side of this common experimental range will not be discussed
further. We evaluate ln k2 of different micelle sizes at several
monomer concentrations from Eqs. (4) and (7)–(10) and plot it
in Fig. 8. In this way, the fastest rate of the two-step nucleation
can be detected, identifying the dominant micelle species N*
in this nucleation mechanism.
The x-axis in the ln k2 plot varies from Nh to N l, which
is the range of the metastable micelle sizes that can adopt the
two-step mechanism for each chosen monomer concentration
C1. For clarity and convenience, we normalize the plots of
ln k2 to extend between 0 and 1. The width of the peak of
nucleation rate, if such a peak exists, is defined as the size
range of micelles with the fraction of 0.5 in the y-axis. All the
parameters involved in the estimation of k2 have been listed
in Appendix A with room temperature for T and the viscosity
of water at room temperature for η. The plots in Fig. 8 show
two main features: the peak of the nucleation rate that occurs
at a certain micelle size N*(C1) and the width of this peak
increasing as the monomer concentration increases.
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FIG. 8. Plots of ln k2 (normalized between 0 and 1)
against the micelle size N for several C1 values (using
an example of ∆αβ = −18 kBT ). The N-axis range in
each plot is between Nh(C1) and N l(C1), where the rel-
evant range of two-step nucleation occurs. The width of
each peak is indicated in the plots.
To understand the fastest growing rate, let us examine
the contributing effects of micelle formation at a rate k+ and
its conversion at a rate kc. For the parameters correspond-
ing to Aβ1–42 (Appendix A), the conversion barrier ∆Fc is
always between 10 and 25 kBT for the micelle size below
40 (which is clearly the maximum micelle size value that
we will encounter). On the other hand, the barrier to form
a micelle, ∆Fmic, starts from roughly 50 kBT at ln C1 = −6.5
and decreases to 20 kBT at ln C1 = 2, meaning that the rate k+
at N = Nh is very small, and then sharply increases as C1 grows
to finally become comparable with kc at high concentrations.
The value of k

at N = Nh is very high, which is easy to see by
inserting Fm = ∆Fmic at N = Nh in Eq. (9). Then k decreases
dramatically as N grows from Nh due to the CN1 e
Fm/kBT factor
in (9). Hence there must exist a particular micelle size N* when
k− ≈ kc. When N < N∗, we have the nucleation rate constant
k2 ≈ kck+/k− = kce−Fm/kBT , which a is growing function of N.
On the other side, at N > N∗, k

is small and k2 ≈ k+, which
is a decreasing function of N. Between these regimes, we will
always find the point N = N* of the fastest rate of the two-step
nucleation.
To put it more physically, when the micelle size is too
small, it suffers a rather large dissociation rate and cannot
undergo the full subsequent conversion into fibrils. As the
micelle size grows bigger, they become less prone to dissoci-
ation and will have adequate time to complete the conversion
process. However, a further growth of micelles will decrease
the micellation rate. In this case, micellation is the rate-limiting
process and the total time of the two-step nucleation will there-
fore increase with the micelle size. Basically, this N* value is
the size where the effect of a slow micellation process starts
to take over other two kinetic processes.
Figure 9 illustrates this effective size of the critical nucleus
N* (giving the “peak rate” in Fig. 8) against the monomer
concentration C1, using three values of the α-β interaction
parameter ∆αβ from its plausible range. At very low monomer
concentrations, this nucleation size N* starts from a larger
value, gradually decreasing to finally reach a plateau that spans
over a broad range of concentrations. (There is an additional
feature: the re-increase of N* for a low ∆αβ = −18 kBT at very
high concentrations, which we do not fully understand and
will not be discussing further.) These values of the “critical
nucleus” size are within the range obtained by the coarse-
grained molecular simulations of Saric´ et al.:29 from 2 to
14; they also fall within the experimentally observed values
(2 to roughly 25).83 Notably, the fact that N* is not a con-
stant value in Fig. 9 indicates the weakness of the assumption
about a fixed, concentration-independent micelle size before
conversion, which was employed in the previous two-step
kinetic model.36 Nevertheless, a typical prediction of the crit-
ical nucleus size N∗ ' 7-8 over a broad range of monomer
concentrations seems to be appropriate. We believe this N*
value is reasonable and is close to the previous work of the
two-step nucleation kinetics of amyloid peptides by Lomakin
et al.,35 which gave the nucleus size of 10, although they
did not consider the conversion process from micelles into
fibrils.
To qualitatively understand the dependence of N* on con-
centration C1, we can use the approximate condition for the
peak of the total rate constant k2, namely, k− ≈ kc, where we
FIG. 9. The plot of the fastest-growing nucleus size N* against ln C1, for three
values of ∆αβ/kBT : 18 (dotted line, circles), 20 (dashed line, squares),
and 22 (solid line, diamonds) from top to bottom. We conclude that a
safe assumption is that N∗ ≈ 7 for Aβ1–42, for a broad range of monomer
concentrations.
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take kc to be a constant (it has only a slow variation with N
compared with k

). From Eq. (9), we know that k

does not
have a power-law dependence on C1, and we further ignore the
electrostatic/entropic repulsion term in Fmic since the micelle
size is quite small and this repulsion free energy is relatively
low in this region. The difference N  Nh, required for this
ratio to reach a constant value, depends on the choice of Nh
due to the nonlinear term in Nα. A small Nh requires a larger
difference compared with higher Nh values. One should fur-
ther notice that Nh depends on C1 and gradually decreases
as C1 increases (see Fig. 5). Therefore, N* is controlled by
two opposite effects: the shift of Nh to a lower value with an
increased ln C1 and the growing N  Nh difference required
for ln k− to reach a specific constant as ln C1 increases. At a
small C1, the shift of Nh wins, causing a larger N* value. As
C1 increases, these two effects may offset each other, explain-
ing the plateau region in Fig. 9. The re-increase of the N*
value with ∆αβ = −18kBT at ln C1 ≥ 2 is likely due to the
other peak condition, that is, k+ ≈ kc. At such a high C1,
the micelle formation rate k+ decreases slowly with N, which
allows the micelle size N to grow more significantly before k+
reaches the required kc value, producing a noticeable increase
in N*.
Strictly, the total nucleation rate in the two-step mech-
anism, k ′2 is the sum of all k2 values of different individual
pathways labeled by the micelle size N, at a given monomer
concentration C1. However, due to the presence of the sharp
peak in k2(N), we may ignore the spread of different nucleus
sizes and only represent nucleation by the peak rate k2(N*). A
comparison of these two values is given in the inset of Fig. 10,
proving that the error in ignoring nucleation pathways other
than N* is very small. This allows us to investigate how k∗2
changes with increasing monomer concentration and propose
possible explanations for the features present in Fig. 10. Impor-
tantly, we do not expect the actual rate of nucleation, k2C1, to
scale as the power law knCN
∗
1 as would be the expectation of
classical nucleation theory.
FIG. 10. The log-log plot of the normalized effective nucleation rate in the
two-step mechanism, ln k2, and in the NP mechanism, ln k1, against the
monomer concentration C1, at three values of ∆αβ = −18 (dotted line),
20 (dashed line), and 22 (solid line). The lines are fitted linear trends of
ln k2, whose slopes are given as approximately 5.9 (black), 5.3 (blue), and
4.8 (red). The bold solid line of ln k1 is not perfectly linear but has the slope
exponent of approximately 2 at higher C1. The inset shows the comparison
of the total rate ln k′2 (squares) and the peak rate ln k∗2 (lines), demonstrating
that the difference is very small.
COMPARISON OF NUCLEATION RATES
With Eqs. (4) and (7), a comparison of rate constants of
the two competing mechanisms, k1(C1) and k2(C1), is plotted
in Fig. 10. Both rate constants are normalized by the same
factor: the k1 value at ln C1 = −6.5, referring to the lowest
monomer concentration case we investigate. The ln k1 curve
is not perfectly linear on the log-log plot of Fig. 10 due to the
two competing time scales in Eq. (4). For the concentration
regime we investigate, the diffusive arrival time τD, which is
proportional to C1, is smaller than the internal re-arrangement
time of peptides, τI . The τD factor is hence screened off, giv-
ing roughly a dependence k1 ∝ C21 in Eq. (4), see Fig. 10. This
implies that if we were to interpret this in the framework of
classical nucleation theory, this would mean that the NP nucle-
ation rate k1C1 = knC31 , which would imply the critical nucleus
size nc = 3. This size would be higher, nc = 4, if the diffusion
time would be dominant, but not in the relevant concentration
regime.
For the three versions of k2, for the three values of the
conversion penalty ∆αβ , there are two features to observe.
First, a linear trend line could be used to fit ln k2 in the
range of ln C1 between 6.5 and 0, which suggests an effec-
tive power-law dependence of the two-step nucleation rate:
k2C1 = knCnc1 . However, the exponent of this power law does
not match the value of the critical nucleus size as we defined
it for the two-step mechanism: N∗ ≈ 7. For illustration, a
power-law slope of CN∗−11 is added to the plot in Fig. 10, to
show that the scaling of k2(C1) is much lower. Moreover, this
slope is not universal and clearly varies with the values of ∆αβ
parameter.
We first focus on how ∆αβ comes into play. At low
monomer concentrations, we found that k2 is first determined
by the relation k2 = k+kc/k, which then changes to k2 = k+ (the
crossover at k

= kc is what determines the fastest growing size
N*). Accordingly, an increase in ∆αβ has a strong effect on the
rate k2 by decreasing the conversion rate kc at low C1. In con-
trast, at higher C1, we have k2 = k+ which does not depend on
∆αβ: different k2 lines overlapping in the high-concentration
regime in Fig. 10.
The crossover concentration when the two-step mecha-
nism starts to overtake the direct NP mechanism of amyloid
nucleation is also strongly dependent on the α-β interaction
energy ∆αβ , which is why it is important to have better esti-
mates of its value. But in all cases, this happens in the low-
to medium-concentration regime. From Fig. 10, we find that
the two-step mechanism takes over from ln C1 = −6 (2.5 µM)
for ∆αβ = −22 kBT, this crossover concentration increasing
to ln C1 = −3 (50 µM) for a lower bound ∆αβ = −18 kBT.
The crossover concentration was given as approximately 8
µM by Auer et al.,37 where the two-step mechanism was also
concluded to take place at a higher concentration than the NP
mechanism.
CONCLUSIONS
We elucidate the kinetics of two alternative amyloid nucle-
ation mechanisms, the direct (NP) nucleation and the two-step
nucleation via an aggregation of α-micelle and its subsequent
conversion into the β filament. We used an equilibrium free
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energy approach to consider the possibilities that the criti-
cal nucleus and favorable micelle size change with monomer
concentration. This analysis of the composite free energy land-
scape in the two-step mechanism allows the use of a simplified
three-state kinetic model and thus the analytical derivation of
the effective nucleation rate constant. We define the critical
nucleation size by the fastest growing rate criterion, having
verified that this rate dominates a practically measured total
rate of nucleation.
We find that theoretically predicted variation of the nucle-
ation rate with monomer concentration could be easily inter-
preted as a power law in the analysis of experimental data
even though the actual expression is not. For the NP mecha-
nism, the critical nucleus size is determined to be the trimer
of the protofilament pair, and this does not change within the
monomer concentration range we investigate. On the other
hand, in the two-step mechanism, the micelle size with the
largest nucleation rate is dependent not only on the monomer
concentration but also on the strength of the interaction
between α- and β-mers (∆αβ). Generally speaking, the opti-
mized micelle size decreases from around 10 to around 7 and
then remains at this value for a wide concentration range, point-
ing out the inappropriateness of the pre-assumption of the fixed
micelle size in the previous kinetic approaches.
Although a nearly power-law relationship of both nucle-
ation rates on monomer concentration is observed, the expo-
nent of the “apparent power law” in the two-step mechanism
has no simple relationship on the critical nucleus size, as
would be expected from the kinetic formalism of classical
nucleation theory. The scaling of k2(C1) also depends on ∆αβ
and is determined by a complex interplay between micella-
tion, conversion, and dissociation processes. Unfortunately,
such complexity makes the rigorous analysis of these effec-
tive power laws hard to carry out. But it is certain that the
critical nucleus size obtained by fitting the Oosawa model or
other kinetic models that all assume the classical nucleation
formula in amyloid aggregation is not actually the real critical
nucleus size. There are many experimental results that give
values for the nucleation parameters kn and nc—in all cases,
taking the “nucleus size” nc fixed at some pre-decided value
(nc = 2 in the work of Knowles et al.,18,21 nc = 10 in the work
of Lomakin et al.,35 etc.). None of that agrees with our pre-
dictions, and so we cannot use the fitted values for kn either.
It would be best to re-analyze the raw data in many of the
published studies in view of our predictions.
One may think of some direct experimental methods of
determining the critical nucleus size that could extract this
important nucleation size (in both mechanisms) and, thus,
compare with our theoretical predictions. Unfortunately, no
such experiments are yet available, and instead molecular
simulations would be a more plausible way to understand the
amyloid nucleation.
It is also important that the theoretical prediction for the
crossover point of concentration where the two-step mecha-
nism takes over from the direct filament nucleation depends
on the strength of a not well-known interaction strength ∆αβ .
Experiment or simulation is also needed to focus on finding a
more accurate value of this parameter, in order for our predic-
tions to become more quantitative. In this context, there has
been a recent simulation study of the amyloid nucleation pro-
cess,84 which gives a detailed and thorough discussion of the
two-step process and its associated kinetics, using the energy
parameters very similar to ours. In that work, the nucleation
rate was expressed as the sum ∑N kc(N)CN , where kc(N) is the
probability for an N-size micelle to undergo α-β conversion
into fibrils and CN is the concentration of the N-size micelles.
Our result in Fig. 8 is analogous to their plot of kc(N)CN , which
also has a maximum at the fastest-growing nucleus size N*.
However, their model only considers a single protofilament
(not the pair) and their coarse-grained discrete interactions of
subunits within the micelle differ from our continuum approxi-
mation, Eq. (5). They also consider a much more narrow range
of concentrations: C1 from 40 µM to 4 mM (compare with our
Figs. 8 and 10). Accordingly, their results differ from ours in
several ways:
1. Their range of an apparent power-law nucleation rate
appears very narrow, only close to the cmc, and they claim
that their optimal size N* does determine this power-law
exponent (which, of course, is not what we have found
in Fig. 10).
2. In our work, the dissociation of micelles is a key factor,
as it stops a too small micelle undergoing conversion. It
was unclear to us whether this dissociation was reflected
in kc(N)CN .
3. They used depleting monomer concentration in their
simulation, essentially reaching a thermal equilibrium
between monomers and micelles. In our case, we had
the rate of micelle formation sufficiently low (k+ with a
high barrier∆Fmic), so the conversion process was signif-
icant well before the equilibrium micelle concentration
was reached.
It is important for experiments to focus on the points
discussed here, in order to differentiate between different
predictions and mechanisms at the stage of early amyloid
nucleation.
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APPENDIX A: VALUES OF Aβ1–42 PARAMETERS
The values of all parameters are summarized in Table I.
An approximate value of ∆c is suggested to be approximately
20 kBT (T refers to room temperature 25 ◦C) in the practice of
coarse-grained molecular simulations.28 It has to be noted that
this value is not a reliable result of rigorous all-atom simula-
tions, as one would have wished and as is the case for many
other energy parameters we use. In the coarse-grained simula-
tion,28 the authors merely assumed this value to be reasonable,
based on the fact that single β-mers are not spontaneously
formed in solution.
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TABLE I. Summary of parameters. The values of bond energies are given in
units of kBT at room temperature, with the main reference to the source where
available.
∆β ∆c ∆s µ
◦ ∆α ∆αβ τI
Value 44 20 22 34.5 17 (1723) 105 s
Reference 50 29 51 86 74 (See below) 58
All-atom simulations were carried out to investigate the
interactions between two protofilaments in the model of
Aβ17–42, which is the fraction of the peptide sequence from
the 17th to the 42nd amino acid residues of the native Aβ1–42
and is believed to be the main cause of the universal structural
motif in Aβ17–42 fibrils. This result suggested a steric zipper
formed on the interface of two protofilaments.85 Thus, the ∆s
value can be roughly estimated to be 22 kBT, the typical
interaction free energy of a steric zipper.51
To estimate the value of µ◦, we connect the theoretical
elongation free energy formula, namely, ∆β + ∆s − µ◦ + ∆c
+ kBT ln (C1/C◦1) from (2), with the experimentally measured
magnitude of elongation free energy of fibrils. Although this
experimentally measured value for Aβ1–42 is not available,
a similar (shorter) amyloidogenic peptide, Aβ1–40, was used
to measure its elongation free energy through evaluating the
monomer concentration in thermal equilibrium with its fib-
rils.86 The result has produced a value of 11.6 kBT in the
Aβ1–40 system. We shall assume that Aβ1–42 should resem-
ble it closely and have roughly the same elongation free
energy. By inserting ∆β of 44 kBT, ∆s of 22 kBT, ∆c of
20 kBT, and the elongation free energy of 11.6 kBT in the
theoretical elongation free energy formula, µ◦ is evaluated as
34.5 kBT.
The value of ∆α cannot be determined from experiments
and can only be investigated by molecular simulations. Nev-
ertheless, different results have been obtained depending on
the constraints on the conformation of peptides that are used
in simulations. In Refs. 28 and 29, ∆α has the value of
8.4 kBT and 6 kBT, respectively, but these values may be
underestimated since each α-mer is assumed to still hold the
same structure as before micellation and can only interact
through one hydrophobic patch on the surface of the native
monomeric state. This scene is unrealistic because micellation
usually undergoes a structural change to become a more stable
state, like collapsed amorphous micelles. On the other hand,
Ref. 74 does not have this pre-assumption and allows peptides
to reorganize its structure to form an amorphous micelle. Even
though it only models the peptides with the core sequence that
forms β-sheet in the aggregation and may thus also under-
value the ∆α term. Despite this defect, we will use the val-
ues given in Ref. 74 to estimate the value of ∆α. The bond
interaction is approximately 19.2 kcal/mol, which is taken
from the amorphous dimer case of Fig. 3 in Ref. 74. The
free energy change due to the entropic loss is evaluated as
9.2 kcal/mol under the assumption that the peptide loses all its
conformational entropy upon bonding in the supplement of it.
Together with these two values, ∆α is roughly 17 kBT.
τI is the time scale for internal α to β rearrangement
of amyloidogenic proteins, which cannot be theoretically
evaluated, as no simple theoretical models are proposed to
include internal friction in a dense protein structure. Although
τI for Aβ1–42 peptide is still unknown, it can be approximated
from the known value for insulin (in Ref. 58) that has the
closest protein length to Aβ1–42 peptide, giving τI as 105 s.
For the ∆αβ value, although all-atomic simulations on the
free energy of one αβ bond in Ref. 29 was implemented, it
had the pre-assumption/constraints on the conformation of
α-mers, not allowed to change from its native monomeric
structure in solution, and the resultant ∆αβ value is doubtable
to be used in the micelle model of this work where α-mers
within a micelle may not have the same conformation as in the
monomeric state. Unfortunately, no other specific experiments
or all-atomic molecular simulations considering this structural
change of monomers into a micelle have been conducted to
determine the value of this coupling energy.
We set the lower limit of ∆αβ by considering its role to
facilitate the conversion process. Equation (5) can be used to
obtain the free energy change from an N-size micelle into the
conversion intermediate with only one α-mer converted. If we
first ignore the electrostatic and entropic repulsion and focus
on the role of the αβ bond free energy, the energy difference
when one α-mer is converted on the surface of the micelle is
∆c + (∆αβ − ∆α) [Nα(N) − Nα(N − 1)]. If ∆αβ equals to ∆α,
it means that conversion of one α-mer on the surface of a
micelle has the same energy as the conversion of one α-mer in
solution, i.e.,∆c in both cases. If |∆αβ | < |∆α |, then it would be
preferable to undergo α-β conversion in solution, which is not
true in practice. In other words, micellation must help facilitate
the conversion of α-mers and lower the free energy barrier
along the conversion process. Therefore, we set the lower limit
of ∆αβ to be 18 kBT in our model, a little higher magnitude
than ∆α. On the other hand, we consider the final conversion
step for intermediates with one α-mer left to fully become
the β-aggregate. This step gives the same free energy states
involved in the elongation process: an α-mer first attaches to
the end of the pre-existing β-aggregate and then converts into
the β-mer. The free energy of the intermediate at x = N  1
shall be higher than the final free energy of the β-aggregate
(x = N) so that the final β-aggregate is more favored than
partially converted intermediates, and the elongation process
will not get thermodynamically trapped in the intermediate
state. We thus have the constraint on the upper limit of ∆αβ:
0 > ∆β + ∆s + ∆c − 2∆αβ . Therefore, ∆αβ should be weaker
than 23 kBT and has its lower limit of 17 kBT as discussed
earlier.
APPENDIX B: DERIVATION OF k1
The shape of monomers can be approximated by a sphere
with the radius of 1 nm from the hydrodynamic radius
experiment of Aβ1–42,87 while the trimer of the paired protofil-
ament (the critical nucleus in the NP mechanism) takes roughly
the shape of a cuboid with dimensions of 46 Å, 46 Å, and
8.4 Å based on the structure of a single β-mer given in Ref. 88.
In this scenario, it is clear that the collision between monomers
and the critical nuclei is the non-spherical case, and in fact, no
theoretical formula of the collision rate is available for such
a complicated shape. Yet, a convenient way to estimate this
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FIG. 11. (a) Sketch of the non-spherical shape of the trimer nucleus, with the
semi-axes Ax1 = (2.3 + 1) nm and Ax2 = (0.42 + 1) nm, defined following the
notations of Ref. 61. (b) A sketch of a fragment of the free energy Fβ,2(N)
illustrating the additional (small) free energy barriers between the consecutive
states of an elongating filament pair.60
structural effect is to approximate it as in the elongated ellip-
soid case, as illustrated in Fig. 11(a), where as long as the center
of mass of one monomer enters the surface of this ellipsoid
(with the trimer being its center), the collision is considered
effective.
In this case, the inverse of the time required for one
monomer to diffuse to or hit the surface of the trimer, 1/τD, is
written as61
1
τD
=
4piDmC1Ax1 2
√
1 − (Ax2/Ax1)2
pi/2 − arctan [Ax2/Ax1 2
√
1 − (Ax2/Ax1)2]
. (B1)
Here, Ax1 and Ax2 are the major and minor semi-axes of the
ellipsoid, respectively. We further let Ax1 equal to half the sum
of the length of the trimer and the monomer diameter, which
is (46 + 20)/2 Å and refers to the case where the monomer
contacts the top surface of trimer. Similarly, Ax2 equals to half
the sum of the height and the monomer diameter, giving (8.4
+ 20)/2 Å and corresponding to the case of side attachment
of one monomer to this trimer. A comparison with the Smolu-
chowski equation and (B1) gives the geometric factor f geo used
in obtaining the k1 value as
fgeo = Ax1
2
√
1 − (Ax2/Ax1)2
pi/2 − arctan [Ax2/Ax1 2
√
1 − (Ax2/Ax1)2]
. (B2)
With Ax1 of 33 Å and Ax2 of 14.2 Å, f geo is estimated roughly
as 26.4 Å.
The constant Dm is assumed to be roughly twice the diffu-
sion coefficient of the spherical monomer: although we know
that the trimer has a different volume, the difference in the dif-
fusion constant between it and the monomer is minor, while
no simple calculation for an accurate mutual diffusion coef-
ficient is available. From the Stokes-Einstein equation, Dm is
expressed in terms of the monomer size r1 and solvent viscos-
ity η as kBT/3piηr1. Putting this relation and (B2) into (B1),
we obtain
1
τD
=
4kBTC1fgeo
3ηr1
. (B3)
Since we take the rate of linear aggregation as the rate of
progressing from N = 3 to N = 4 (the process repeats with the
same parameters further on due to the linear N-dependence of
the free energy, Fig. 4). Therefore, this rate is determined by
the barrier to reach the critical nucleation size N = 3 of a paired
protofilament plus the small free energy barrier for monomer
aggregation on regular filament elongation, see Fig. 11(b) and
the detailed simulations.60 Putting Eq. (B3) into Eq. (3), we
finally obtain Eq. (4).
Why do the filaments not effectively depolymerize after
reaching and exceeding the critical nucleus size? The rate
constant of depolymerization kd (that is, the transition from
N = 4 back to N = 3) is controlled by the activation energy
Fβ,2(3) − Fβ,2(4) + ∆Fel and its ratio to kp, the further poly-
merization rate constant, is proportional to the exponential
factor
kd
kp
∝ exp
(
−Fβ,2(3) − Fβ,2(4)kBT
)
≈ exp (−11.5 − ln C1), (B4)
using (2) with N ≥ 3, and the values of energy parameters
in Table I. At the lowest limit of our examined concentra-
tions, ln C1 = −6.5 and the ratio of reverse-forward rates is
∝ exp−5: even this upper bound is low enough to consider
only the forward rate of filament polymerization.
APPENDIX C: DERIVATION OF k2
We consider a system of only three states: Smono,
monomers, Sint, the intermediate species, and Saggr , the final
β-aggregate. This system can go from Smono to Sint with the
micellation rate constant (k+), Sint to Saggr with the conversion
rate constant (kc), and Sint to Smono with the dissociation rate
constant (k

). At Sint, the system can either dissociate back into
monomers or fully convert into the β-aggregate. The inverse
conversion from Saggr is not considered based on the fact that
the elongation rate of any β-aggregate that exceeds the critical
nucleus size is rather fast, leaving almost no chance to reverse
the aggregation. The set of kinetic equations for each state are
written as
dC1
dt = k−Cint − k+C1,
dCint
dt = −(k− + kc)Cint + k+C1,
dCaggr
dt = kcCint,
(C1)
where C1, Cint, and Caggr are defined as the concentrations
of the Smono (monomers), Sint (intermediate), and Saggr (the
final β-aggregate) states, respectively. Our aim is to find the
average time for the system to first reach the final state Saggr
considering all the possible paths, that is, to find the average
nucleation rate constant k2 defined below,
dCaggr
dt = k2C1. (C2)
All the rate constants defined in Eqs. (C1) and (C2) have the
dimension of the inverse of time, which then can be used to
find the time scale involved in this nucleation process. The time
required to travel from Smono to Sint is defined as τ+, which is
simply 1/k+. Similarly, τ−, the time from Sint to Smono, is 1/k,
while τc, the time from Sint to Saggr , equals to 1/kc.
To find the average time for nucleation, we need to find
out the time required for each path. For example, the first path
is Smono → Sint → Saggr and the second path corresponds to
Smono → Sint → Smono → Sint → Saggr . All other paths will
have more than two times of dissociating back and associating
into a micelle again. For the first path, the total travel time is
(τ+ + τc), whereas the second path requires [(τ+ + τ−) + 1 ∗ (τ+
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+ τc)]. A general form for the travel time of the (n + 1)th path,
i.e., τn+1, shall be
τn+1 = (τ+ + τ−) + n(τ+ + τc). (C3)
In this system, only at Sint the decision is made to fully
convert to the aggregate or to dissociate back into monomers.
The probability to convert is denoted as Pc, which is propor-
tional to kc, while the probability to dissociate back is P and
is proportional to k

. We then have the normalized probability
of conversion and dissociation,
Pc =
kc
kc + k−
, P− =
k−
kc + k−
. (C4)
For the (n + 1)th path, the system needs to dissociate back
n times and finally a conversion follows, and the probability
for this to happen, Pn+1, is readily written as
Pn+1 = Pn−Pc. (C5)
The average time to reach Saggr , denoted as τave, is the sum-
mation of products of the time required for different paths and
their probability to happen,
τave = Σ
∞
0 τn+1Pn+1. (C6)
Inserting Eqs. (C3)–(C5) into (C6) and taking the inverse of
it, we arrive at the formula of (7).
APPENDIX D: DERIVATION OF k+
The rate collisions between a monomer and a micelle
of size (N  1) are expressed by the Smoluchowski rela-
tion using the mutual diffusion coefficient Dm = D1 + DN1:
4piDm(r1 + rN−1)C1CN−1. Here r1 is the radius of a monomer,
while rN1 is the radius of an (N  1)-size micelle. CN1 is the
concentration of the (N  1)-size micelle, which is between the
Nh and N l sizes in the three-state kinetic model (in order to
have a metastable/intermediate state). This rate, by definition,
is equal to k+C1, which is how we shall determine this rate
constant.
Due to the micellation free energy barrier for monomers to
cross to aggregate into this (N  1)-size micelle, we assume a
pre-thermal equilibrium for the concentrations of the micelles
whose size is smaller than Nh, the micelle size that gives the
micellation free energy barrier. Accordingly, we can easily
write the CNh term as
CNh = C1e
−∆Fmic
kBT , (D1)
where∆Fmic refers to the micellation free energy and is simply
(5) at N = Nh.
In order for this Nh-size micelle to aggregate into
(N 1)-size, it has to adsorb additional (N Nh 1) monomers.
We may further assume that this Nh-size micelle acts as a deep
absorbing sink. Monomers are adsorbed as soon as they con-
tact the surface of the Nh-size micelle, which requires that the
center of mass of one monomer to fall inside the spherical vol-
ume of 4pi
(
rNh + r1
)3 /3, a region that is bound by the radii of
one monomer and the pre-existing micelle of Nh size. The vol-
ume conservation is implemented to estimate rNh as r1 3
√
Nh. In
this way, the probability of adsorption of n monomers to this
pre-micelle, Pa,n, is
Pads,n =
[
4pir31
(
1 + 3
√
Nh
)3
C1/3
]n
. (D2)
With (D1) and (D2), CN1 is given as
CN−1 = Pads,N−Nh−1CNh
=
[
4
3pir
3
1 (1 + 3
√
Nh)3
]N−Nh−1
e−∆Fmic/kBT CN−Nh1 . (D3)
For the estimation of the mutual diffusion coefficient Dm,
the Stokes-Einstein equation is used to express Dm in terms of
the viscosity of solvents η, temperature T, and the size of the
micelle and monomer. Together with rN1 expressed in r1, it
gives
Dm = D1 + DN−1 =
kBT
6piηr1
(
1 +
1
3√N − 1
)
. (D4)
Inserting (D1) and (D3) into 4piDmCN−1, we obtain k+ as
written in (8).
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